These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7349318)

  • 1. Bioavailability of oxytetracycline dihydrate tablets in dogs.
    Cooke RG; Knifton A; Murdoch DB; Yacoub IS
    J Vet Pharmacol Ther; 1981 Mar; 4(1):11-3. PubMed ID: 7349318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability and dissolution of different formulations of oxytetracycline preparations.
    Hart A; Barber HE; Calvey TN
    Br J Clin Pharmacol; 1975 Jun; 2(3):277-80. PubMed ID: 10944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological availability and in vitro dissolution of oxytetracycline dihydrate tablets.
    Barber HE; Calvey TN; Muir K; Hart A
    Br J Clin Pharmacol; 1974 Oct; 1(5):405-8. PubMed ID: 22454918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and bioavailability of directly compressed oxytetracycline hydrochloride tablets.
    Aboutaleb AE; Tout SA
    Pharmazie; 1983 Mar; 38(3):186-8. PubMed ID: 6867079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and dosage of oxytetracycline in dogs.
    Baggot JD; Powers TE; Powers JD; Kowalski JJ; Kerr KM
    Res Vet Sci; 1978 Jan; 24(1):77-81. PubMed ID: 625605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of the bioavailability of diazepam from uncoated tablets in beagle dogs with its dissolution rate and bioavailability in humans.
    Ogata H; Aoyagi N; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Shimamoto T; Yashiki T; Ogawa Y; Uda Y; Nishida Y
    Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):576-81. PubMed ID: 6818163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin pharmacokinetics and oral absorption of generic ciprofloxacin tablets in dogs.
    Papich MG
    Am J Vet Res; 2012 Jul; 73(7):1085-91. PubMed ID: 22738062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytetracycline concentrations in plasma and lung of healthy and pneumonic calves, using two oxytetracycline preparations.
    Ames TR; Patterson EB
    Am J Vet Res; 1985 Dec; 46(12):2471-3. PubMed ID: 3909863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the serum pharmacokinetics of a long acting and a conventional oxytetracycline injection.
    Davey LA; Ferber MT; Kaye B
    Vet Rec; 1985 Oct; 117(17):426-9. PubMed ID: 4071932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood levels of oxytetracycline in dogs after oral administration.
    Immelman A
    J S Afr Vet Assoc; 1977 Oct; 48(3):183-6. PubMed ID: 599529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics, bioavailability and renal clearance of five parenteral oxytetracycline-20% formulations in dairy cows.
    Mevius DJ; Nouws JF; Breukink HJ; Vree TB; Driessens F; Verkaik R
    Vet Q; 1986 Oct; 8(4):285-94. PubMed ID: 3798710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans.
    Lin Z; Li M; Gehring R; Riviere JE
    J Pharm Sci; 2015 Jan; 104(1):233-43. PubMed ID: 25407474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posaconazole pharmacokinetics after administration of an intravenous solution, oral suspension, and delayed-release tablet to dogs.
    Kendall J; Papich MG
    Am J Vet Res; 2015 May; 76(5):454-9. PubMed ID: 25909378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytetracycline plasma levels in dogs after intramuscular administration of two formulations.
    Immelman A; Dreyer G
    J S Afr Vet Assoc; 1981 Sep; 52(3):191-3. PubMed ID: 7310789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of griseofulvin from tablets in beagle dogs and correlation with dissolution rate and bioavailability in humans.
    Aoyagi N; Ogata H; Kaniwa N; Koibuchi M; Shibazaki T; Ejima A; Tamaki N; Kamimura H; Katougi Y; Omi Y
    J Pharm Sci; 1982 Oct; 71(10):1169-72. PubMed ID: 7143218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability of Nalidixic acid from uncoated tablets in humans--Part II: Bioavailability in beagles and its correlation with bioavailability in humans and in vitro dissolution rates.
    Ogata H; Aoyagi N; Kaniwa N; Shibazaki T; Ejima A; Takasugi N; Mafune E; Hayashi T; Suwa K
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):240-5. PubMed ID: 6746147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The availability of tetracyclines in calves.
    Luthman J; Jacobsson SO
    Nord Vet Med; 1983; 35(7-9):292-9. PubMed ID: 6647022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics and local tolerance of three injectable oxytetracycline formulations in pigs.
    Banting AL; Baggot JD
    J Vet Pharmacol Ther; 1996 Feb; 19(1):50-5. PubMed ID: 8992026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmaceutical and biological availability of commercial preparations of furosemide.
    Stüber W; Mutschler E; Steinbach D
    Arzneimittelforschung; 1982; 32(6):693-7. PubMed ID: 6889429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.